| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $449.0M | -5.3% |
| Cost of Revenue | $48.3M | -3.7% |
| Gross Profit | $400.7M | -5.5% |
| R&D Expense | $124.6M | -7.6% |
| SG&A Expense | $67.6M | -6.1% |
| Operating Income | -$19.4M | -1633.9% |
| Pre-tax Income | -$30.6M | -371.3% |
| Income Tax | $2.4M | -62.6% |
| Net Income | -$33.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $188.0M | -13.9% |
| Accounts Receivable | $25.7M | +9.4% |
| Current Assets | $448.9M | -17.4% |
| Total Assets | $569.7M | -14.2% |
| Current Liabilities | $70.9M | -13.1% |
| Long-term Debt | $544.8M | +0.2% |
| Total Liabilities | $646.9M | -0.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.0M | -76.0% |
| Capital Expenditures | $1.1M | +16.9% |
| Investing Cash Flow | $65.1M | +205.0% |
| Financing Cash Flow | -$106.5M | -120.1% |
| Free Cash Flow | $9.9M | -78.0% |
| -156.7% |
| EPS (Basic) | -$0.37 | -184.6% |
| EPS (Diluted) | -$0.37 | -184.6% |
| Stockholders' Equity |
| -$77.2M |
| -674.8% |